Outcomes
death
DISEASE PROGRESSION, DISEASE, CANCER PROGRESSION
Treatment response and cancer progression were assessed using RECIST 1.1. The primary endpoint was defined as the proportion of patients alive without disease progression at two months. Secondary endpoints were progression-free survival (PFS) (calculated from the start of treatment start to the date of first documented progression or the death of any cause) and overall survival (OS) (recorded from the first day of treatment until the death of any cause) using the Kaplan-Meier method. The treatment response of each patient was assigned to the following categories: complete, partial, stable disease, and progressive disease.